2010
DOI: 10.1111/j.1365-3083.2010.02412.x
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Alloantigen‐Primed Memory CD4+ and CD8+ T Cells by Hematopoietic Chimerism in Mice

Abstract: Donor‐reactive memory T cells present a special hurdle in transplantation. Although hematopoietic chimerism is effective for inducing donor‐specific tolerance, the effects on memory T cells are unclear. Here, we induced stable chimerism and tolerance in mice (Tolerance group, n = 6) by donor‐specific transfusion (DST) plus anti‐CD154 monoclonal antibody (mAb), avoiding the toxic myeloablative conditioning treatment to assist bone marrow transplantation (DST/aCD154&BMTx). We then transferred memory CD4+ or CD8+… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2012
2012
2012
2012

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…Preclinical studies demonstrated promising data on the replacement of calcineurin inhibitors (CNI) by less nephrotoxic immunosuppressive drugs, such as mTOR inhibitors or costimulatory blockade, or even induction of tolerance. Most promising results came from T(/B)-cell depletion and costimulatory blockade, alone or in combination with hematopoetic stem cell transplantation (2)(3)(4)(5)(6).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Preclinical studies demonstrated promising data on the replacement of calcineurin inhibitors (CNI) by less nephrotoxic immunosuppressive drugs, such as mTOR inhibitors or costimulatory blockade, or even induction of tolerance. Most promising results came from T(/B)-cell depletion and costimulatory blockade, alone or in combination with hematopoetic stem cell transplantation (2)(3)(4)(5)(6).…”
Section: Introductionmentioning
confidence: 99%
“…prolonged ischemia, donor age, chronic diseases, HLA mismatch), the recipients immunological history is a key factor determining the individual responsiveness to an allograft (6). Memory T cells (T mem ) that cause accelerated graft rejection develop through previous transplantations, blood transfusions, and pregnancies, but also through exposure to environmental antigens (heterologous immunity) (17,18).…”
Section: Introductionmentioning
confidence: 99%